This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Apogee Therapeutics, Inc. -0.08%
Arcturus Therapeutics +1.34%
CSX Corporation -0.32%
Life360, Inc. -6.26%
Union Pacific Corporation -0.35%
Apogee Therapeutics, Inc. APGE | 86.45 | -0.08% |
Arcturus Therapeutics ARCT | 8.33 | +1.34% |
CSX Corporation CSX | 42.35 | -0.32% |
Life360, Inc. LIF | 38.93 | -6.26% |
Union Pacific Corporation UNP | 250.26 | -0.35% |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Evercore ISI Group analyst Jonathan Chappell downgraded CSX Corp (NASDAQ:CSX) from Outperform to In-Line and raised the price target from $40 to $41. CSX shares closed at $39.64 on Wednesday. See how other analysts view this stock.
- Raymond James analyst Joseph Altobello downgraded Xponential Fitness Inc (NYSE:XPOF) from Strong Buy to Market Perform. Xponential Fitness shares closed at $5.67 on Wednesday. See how other analysts view this stock.
- DA Davidson analyst Wyatt Swanson downgraded Life360 (NASDAQ:LIF) from Buy to Neutral and lowered the price target from $70 to $40. Life360 shares closed at $40.70 on Wednesday. See how other analysts view this stock.
Considering buying XPOF stock? Here’s what analysts think:
Photo via Shutterstock
